FXR AGONIST INDUCED INTESTINAL FGF15/19 REGULATES FXR SIGNALING IN LIVER IN LITHOCHOLIC ACID DIET-INDUCED ACUTE CHOLANGIOPATHY MOUSE MODEL

被引：0
|
作者：
Ghosh, Swati [1 ]
Devereaux, Michael W. [1 ]
Anderson, Aimee [1 ]
Orlicky, David J. [2 ]
Sokol, Ronald J. [1 ,3 ]
机构：
[1] Univ Colorado, Dept Pediat, Sch Med, Aurora, CO USA
[2] Univ Colorado, Dept Pathol, Aurora, CO USA
[3] Childrens Hosp Colorado, Digest Hlth Inst, Aurora, CO USA
来源：
HEPATOLOGY | 2023年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
4625-C
引用
收藏
页码：S2112 / S2113
页数：2
相关论文
共 50 条
  • [21] Therapeutic Potential of Danyankang Capsule in High-Fat Diet-Induced Cholelithiasis and Its Impact on Liver FXR Signaling and Gut Microbiota
    Zhou, Lin
    Zhang, Chu -Ling
    Jiang, Kun
    Cheng, Hong -Yu
    Xiong, Wen -Wen
    Zhu, Ji-Xiao
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2024, 47 (03) : 680 - 691
  • [22] FROM MICE TO MEN - CHANGES IN FGF15/19 EXPRESSION AND BILE ACID LEVELS AS SENSITIVE MARKERS OF PHARMACOLOGICAL FXR ACTIVATION; RESULTS FROM HUMAN PHASE I AND ANIMAL STUDIES USING THE POTENTAND SELECTIVE FXR AGONIST PX-102
    Hambruch, E.
    Krol, H.
    Perovic-Ottstadt, S.
    Hornberger, M.
    Steeneck, C.
    Kinzel, O.
    Deuschle, U.
    Birkel, M.
    Kremoser, C.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S478 - S478
  • [23] M480, a novel non-bile acid FXR agonist, shows improvement across multiple parameters in a diet-induced obese mouse model with biopsy-confirmed NASH
    Wagner, B.
    Brigham, D.
    Lee, K. -J.
    Ortiz, A.
    Lu, N.
    Douglas, K.
    Govek, S.
    Feigh, M.
    Veidal, S.
    Vrang, N.
    Song, K.
    Smith, N.
    Dedman, H.
    Milik, A.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S433 - S433
  • [24] MET409, a Potent, Non-Bile Acid Sustained FXR Agonist, Shows Rapid Disease Reversal in a Diet-Induced Obese Mouse Model of Biopsy-Confirmed Nash
    Wagner, Brandee
    Govek, Steve
    Nagasawa, Johnny
    Douglas, Karensa
    Dedman, Harty
    Milik, Angelica
    Lee, Kyoung-Jin
    Ortiz, Alvaro
    Qian, Jing
    Lu, Nhin
    Liu, Xueqing
    Bischoff, Eric
    Voldem-Clausen, Kristoffer
    Veidal, Sanne
    Feigh, Michael
    Song, Ken
    Smith, Nick
    HEPATOLOGY, 2018, 68 : 1006A - 1006A
  • [25] Atorvastatin protects against liver and vascular damage in a model of diet induced steatohepatitis by resetting FXR and GPBAR1 signaling
    Marchiano, Silvia
    Biagioli, Michele
    Roselli, Rosalinda
    Zampella, Angela
    Di Giorgio, Cristina
    Bordoni, Martina
    Bellini, Rachele
    Morretta, Elva
    Monti, Maria Chiara
    Distrutti, Eleonora
    Fiorucci, Stefano
    FASEB JOURNAL, 2022, 36 (01):
  • [26] Salvia-Nelumbinis naturalis extract protects mice against MCD diet-induced steatohepatitis via activation of colonic FXR-FGF15 pathway
    Li, Chunlin
    Zhou, Wenjun
    Li, Meng
    Shu, Xiangbing
    Zhang, Li
    Ji, Guang
    BIOMEDICINE & PHARMACOTHERAPY, 2021, 139
  • [27] Detailed Analyses of the Antifibrotic effects of INT-767, a dual FXR/TGR5 agonist, in an obese mouse model of diet-induced and biopsy-confirmed NASH
    Veidal, Sanne Skovgaard
    Feigh, Michael
    Hansen, Henrik B.
    Jelsing, Jacob
    Vrang, Niels
    Petitjean, Matthieu
    Chen, Li
    Young, Mark
    Roth, Jonathan D.
    HEPATOLOGY, 2017, 66 : 1044A - 1044A
  • [28] Fucogalactan Sulfate (FS) from Laminaria japonica Regulates Lipid Metabolism in Diet-Induced Humanized Dyslipidemia Mice via an Intestinal FXR-FGF19-CYP7A1/CYP8B1 Pathway
    Song, Jiangping
    Lu, Xingyu
    Liu, Denghong
    Zhang, Yuwei
    Zhai, Xiaoning
    Zhou, Liuyang
    Gao, Jie
    JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2023, 71 (38) : 14027 - 14037
  • [29] Lusianthridin ameliorates high fat diet-induced metabolic dysfunction-associated fatty liver disease via activation of FXR signaling pathway.
    Tang, Xiaowen
    Liao, Qi
    Li, Qinqin
    Jiang, Linshan
    Li, Wei
    Xu, Jie
    Xiong, Aizhen
    Wang, Rufeng
    Zhao, Jing
    Wang, Zhengtao
    Ding, Lili
    Yang, Li
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2024, 965
  • [30] Prophylactic and therapeutic hepatoprotective effects of the dual FXR/TGR5 agonist INT-767 in the GAN diet-induced ob/ob mouse model of advanced MASH with progressive fibrosis
    Nohr-Meldgaard, Jacob
    Pors, Susanne
    Olsen, Rebecca Wendelbo
    Hansen, Henrik B.
    Feigh, Michael
    JOURNAL OF HEPATOLOGY, 2024, 80 : S566 - S567
12345